Sign inJoin waitlistJoin the waitlist

RS

Robert Stuver

Assistant Attending Physician · New York Presbyterian Hospital

Credentials: · · · · ·

History

Memorial Sloan Kettering Cancer Center · Memorial Hospital for Cancer and allied Diseases
2023–Present

Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
2020–2023
Internal Medicine
Beth Israel Deaconess Medical Center
2017–2020
State University of New York Upstate Medical University
2013–2017

Research

Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma…
American Journal of Hematology · 2019 · First of 13 authors · 38 citations
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)
Review · Blood · 2024 · 31 citations
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
Blood Advances · 2023 · 27 citations

SH
Steven Horwitz
29 papers
AM
Alison Moskowitz
28 papers
ZE
Zachary Epstein-Peterson
18 papers · 8 as a fellow
Paola Ghione
13 papers
AD
Ahmet Dogan
12 papers
AN
Ariela Noy
12 papers
AZ
Andrew Zelenetz
11 papers
GS
Gilles Salles
11 papers
Lia Palomba
11 papers
Santosha Vardhana
11 papers
LF
Lorenzo Falchi
10 papers · 1 as a fellow
AK
Anita Kumar
9 papers

Clinical trials

A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
Principal investigator · Recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
2025–2031
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2024–2027
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
Site PI · Recruiting · Phase 1, Phase 2
Step Pharma, SAS
2022–2026